Harnessing the Power of the Digital Exhaust and Digital ATM in Wellness Programs

11:50 - 12:25

Clinical decision-making using diagnostic, prognostic, and monitoring biomarkers requires coordination between the healthcare and technology industries and careful design of longitudinal efficacy studies. Community health providers and pharmacies are poised to play a pivotal point‑of‑care role by helping capture prodromal diagnostic data and incorporating biomarker monitoring into wellness programs.  A model for the pharmaceutical in­dustry to embrace these patient engagement opportunities is outlined together with recent advances in connected care and digital enabled treatment solutions.

Graham B Jones, Director of Innovation, Novartis